Alan D. Brooks

2.1k citations

50 papers · 1.6k indexed · h-index 24

Immunology top 5%
- Immunotherapy and Immune Responses 7
- Immune Cell Function and Interaction 5
Oncology top 10%
- Cancer-related Molecular Pathways 4
Complementary and alternative medicine top 5%
- Phytochemicals and Medicinal Plants 6
Health top 10%
- Vaccine Coverage and Hesitancy 10
Hematology top 10%
Molecular Biology
- Cell death mechanisms and regulation 12
- Ubiquitin and proteasome pathways 4
Pediatrics, Perinatology and Child Health
- Global Maternal and Child Health 5

Co-authors: Thomas J. Sayers Robert H. Wiltrout Naoko Seki Mark J. Smyth William J. Murphy Timothy Back Peter J. Elliott Bruce R. Blazar
Cited by: Immunology Oncology Complementary and alternative medicine
Journals: The Journal of Immunology (6 papers)Vaccine (4 papers)Cancer Research (4 papers)
Partner nations: United States Switzerland Australia

In The Last Decade

Alan D. Brooks

48 papers receiving 1.6k citations

Peers

Countries citing papers authored by Alan D. Brooks

Since Specialization

Citations

This map shows the geographic impact of Alan D. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Brooks more than expected).

Fields of papers citing papers by Alan D. Brooks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Brooks. The network helps show where Alan D. Brooks may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alan D. Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan D. Brooks Line = papers co-authored together Alan D. Brooks links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Implementing the immunization agenda 2030: A framework for action through coordinated planning, monitoring & evaluation, ownership & accountability, and communications & advocacy Vaccine ·Ann Lindstrand,Eric E. Mast,Kathryn A. Welby,冉瑞芳,D.Usmonova D.Gulamova,Alan D. Brooks,Eul-Kyoo Bae,Robin Nandy,Katherine L. O’Brien	2023	17
2	Immunization programs to support primary health care and achieve universal health coverage Vaccine ·Diana Chang Blanc,John Grundy,Samir V. Sodha,Thomas O’Connell,M. Kokoszyńskiej,Nhieu V Nguyen,Tove K. Ryman,Minal Patel,دکتر محمد رضا فرودی جهرمی,Alan D. Brooks,Brian Wahl,Naor Bar‐Zeev,Robin Nandy,Ann Lindstrand	2022	13
3	Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins Cancer Research ·Poonam Tewary,Alan D. Brooks,Ya-Ming Xu,E. M. Kithsiri Wijeratne,Ashley L. Babyak,Timothy Back,Raj Chari,Christine N. Evans,Curtis J. Henrich,Thomas J. Meyer,Elijah F. Edmondson,Maria Teresa P. de Aquino,Thanigaivelan Kanagasabai,Anil Shanker,A. A. Leslie Gunatilaka,Thomas J. Sayers	2021	12
4	Cytotoxic and other withanolides from aeroponically grown Physalis philadelphica Phytochemistry ·Ya-ming Xu,E. M. Kithsiri Wijeratne,Alan D. Brooks,Poonam Tewary,Li‐Jiang Xuan,Peni Lestari Hestiningtyas,Thomas J. Sayers,A. A. Leslie Gunatilaka	2018	28
5	Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries’ supply chain transformations in 2016–2020 Vaccine ·Alan D. Brooks,Y.‐J. Wang,Tajika Taichi	2017	19
6	Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity Cancer Research ·Anil Shanker,Samuel T. Pellom,C. Starren,Menaka C. Thounaojam,D Libei,Alan D. Brooks,Hideo Yagita∥,Daniel W. McVicar,William J. Murphy,Dan L. Longo,Thomas J. Sayers	2015	23
7	Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions Health Policy and Planning ·Alan D. Brooks,Yancarla Mary Conde Canaviri	2012	9
8	Ensemble Modeling of the Likely Public Health Impact of a Pre-Erythrocytic Malaria Vaccine PLoS Medicine ·Thomas A. Smith,Amanda Ross,Nicolás Maire,Nakul Chitnis,DeepaliU Kulkarni,Diggory Hardy,Alan D. Brooks,Melissa A. Penny,Marcel Tanner	2012	85
9	Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission PLoS ONE ·Alan D. Brooks,Olivier Briët,Diggory Hardy,Richard W. Steketee,Thomas A. Smith	2012	12
10	Implementing new health interventions in developing countries: why do we lose a decade or more? BMC Public Health ·Alan D. Brooks,Thomas A. Smith,Don de Savigny,Christian Lengeler	2012	17
11	Adoption of new health products in low and middle income settings: how product development partnerships can support country decision making Health Research Policy and Systems ·William A. Wells,Alan D. Brooks	2011	9
12	Effects of cucurbitacins on cell morphology are associated with sensitization of renal carcinoma cells to TRAIL-induced apoptosis APOPTOSIS ·Curtis J. Henrich,Cheryl L. Thomas,Alan D. Brooks,Nancy L. Booth,Amal Alwasidi,Khartoum.,James B. McMahon,Thomas J. Sayers	2011	13
13	Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex Molecular Cancer Research ·Alan D. Brooks,Kristen M. Jacobsen,Wenqing Li,Anil Shanker,Thomas J. Sayers	2010	54
14	WHO policy development processes for a new vaccine: case study of malaria vaccines Malaria Journal ·Julie B. Milstien,Vicky Cárdenas,James Allan Cheyne,Alan D. Brooks	2010	15
15	Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity Cancer Research ·Anil Shanker,Alan D. Brooks,Kristen M. Jacobsen,John W. Wine,Robert H. Wiltrout,Hideo Yagita∥,Thomas J. Sayers	2009	38
16	Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis Cancer Immunology Immunotherapy ·Alan D. Brooks,Thomas J. Sayers	2004	32
17	Prospective population-based incidence of Haemophilus influenzae type b meningitis in Thailand Vaccine ·Supachai Rerks‐Ngarm,Harold E. Lee,Supamit Chunsuttiwat,Charung Muangchana,Damien Jolley,Alan D. Brooks,Surang Dejsirilert,A.M.,Malcolm Guiver,Prayura Kunasol,James E. Maynard,Beverley‐Ann Biggs,Mark C. Steinhoff	2003	34
18	Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin The Journal of Immunology ·Naoko Seki,Alan D. Brooks,Clive R.D. Carter,Timothy Back,Patricia Blessing,Mark J. Smyth,Robert H. Wiltrout,Thomas J. Sayers	2002	111
19	The Restricted Expression of Granzyme M in Human Lymphocytes The Journal of Immunology ·Thomas J. Sayers,Alan D. Brooks,Jerrold M. Ward,Tomoaki Hoshino,A. Quidor,Gordon Wiegand,Alexsandra Calic,Mark J. Smyth	2001	77
20	IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells The Journal of Immunology ·Jong‐Keuk Lee,Thomas J. Sayers,Alan D. Brooks,Timothy Back,Howard A. Young,Kristin L. Komschlies,Jon M. Wigginton,Robert H. Wiltrout	2000	61

About Alan D. Brooks

Alan D. Brooks is a scholar working on Health, Business and International Management, Complementary and alternative medicine, Immunology and Internal Medicine, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (12 papers), Vaccine Coverage and Hesitancy (10 papers), Immunotherapy and Immune Responses (7 papers), Phytochemicals and Medicinal Plants (6 papers), Immune Cell Function and Interaction (5 papers), Global Maternal and Child Health (5 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer-related Molecular Pathways (4 papers). The work is most often cited by research in Immunology (593 citations), Oncology (444 citations), Complementary and alternative medicine (133 citations), Health (98 citations) and Hematology (110 citations). Alan D. Brooks has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Thomas J. Sayers, Robert H. Wiltrout, Naoko Seki, Mark J. Smyth, William J. Murphy, Timothy Back, Peter J. Elliott, Bruce R. Blazar, Hideo Yagita∥ and Jon M. Wigginton. Their work appears in journals such as The Journal of Immunology, Vaccine, Cancer Research, Cancer Immunology Immunotherapy and Journal of Natural Products.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact